Spotlight on Israeli startups - Corneat Vision - artificial cornea

Corneat Vision can help over 60 million blind eyes around the world.

By JERUSALEM POST STAFF
May 21, 2019 15:30
Spotlight on Israeli startups - Corneat Vision - artificial cornea

Corneat Vision. (photo credit: ROMAN PORETSKI)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later



Corneat Vision is creating an artificial cornea that can help people suffering from corneal blindness regain their eyesight. Located in central Israel's Raanana, they are currently concluding the pre-clinical phase.

Corneat - Artificial cornea
Company name:
Corneat Vision Ltd

Name of the CEO / Names of the entrepreneurs:
Almog Aley-Raz, CEO & VP R&D
Gilad Litvin, MD. CMO

Year of founding: 2015


Line of Business:
Medical Devices - Ophthalmology

Location:
Raanana

Status:
We are currently concluding the pre-clinical phase and are planned to enter the clinical phase in June 2019. Two clinical studies are planned with sites in Israel, Canada, US, France, and China. Our first device, which is a tissue substitute for ophthalmic surgeries will hit the market in late 2020 with the artificial cornea following mid-2021.
 

For more information, visit: https://www.corneat.com/



Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

June 25, 2019
Israeli technology selected to fight severe drought in South Africa

By ZACHARY KEYSER

Cookie Settings